[10] References [edit] 1 2 3 GRCh38: Ensembl release 89: ENSG00000211445 Ensembl, May 2017 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000018339 Ensembl, May 2017 "Human PubMed Reference:"
GLP-1 medications reduce visceral adipose tissue volume alongside overall fat loss, improving cardiometabolic health markers
These drugs still carry important warnings and contraindications, and serious side effects can happen even at low doses
You may be able to minimize skin stretching, and these effects, by maintaining good nutrition and hydration, and undergoing gradual rather than rapid weight loss under the care of a physician
Medical supervision ensures proper dosing, lab monitoring, and adjustments based on your bodys unique response